Investing in disruptive,
early-stage biopharma
companies across Europe.

Supporting the development of trully transformational therapies across all modalities and disease areas.

Working closely with our portfolio companies to bring novel medical treatments to patients in need.

We invest across Europe
in early-stage biopharma companies developping new therapeutics

€52 million

biotech-focused fund backed by the
European Investment Fund and other
public and private investors.

Enhancing
 transformative treatments

Biovance Capital works closely with entrepeneurs to build leading companies with transformative treatments for patients in need. We invest in seed and Series A rounds and typically bring additional investors to add value and mitigate risk.

We grow stronger,
together

We have developed a wide network across Europe that includes research institutes, incubators and accelerators. Through this network, we have access to a rich pipeline of potential investments.

What our team members have to say

As the first-ever biotech dedicated fund, Biovance Capital Fund I marks a
significant milestone in the development of Portugal’s biomedical ecosystem. We are thrilled to launch
this fund and support innovative biotech companies across Europe. We are deeply grateful to our investors for their trust and ongoing support.

Ricardo Perdigão Henriques

Managing Partner – Biovance Capital

What our team members have to say

At Biovance, we believe the future of medicine lies in the hands of visionary scientists and groundbreaking innovations. Our mission is to empower pioneers with the resources to transform lives and redefine the boundaries of what’s possible.

João Incio, MD/PhD

General Managel – Biovance Capital

With over twenty years fostering collaborations between industry and academia in Portugal’s largest health research institute, I am thrilled to contribute to propel exceptional biomedical research from Europe onto the global stage.

André Albergaria, PhD

Principal – Biovance Capital

Our latest news

No Posts Found!

Get our news
directly in the email

 

Subscribe to our newsletter and you’ll get them directly to your e-mail.

Our mission is to
 empower entrepeneurs
to reach new therapies.

Dive in